Mouse Cav1/Cav/Cav-1 ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_007616.4)

SKU: pGMAAV000143
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Mouse Cav1/Cav/Cav-1 Adeno-associated virus expression plasmid (ITR-vector) for Cav1 AAV packaging, Cav1 AAV production.The purified Mouse Cav1/Cav/Cav-1 AAV particle serves as an invaluable asset for in-depth in vivo Cav1 studies, mechanism of action (MOA) research, and the evolution of Cav1-associated gene therapy strategies.

Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.


Purchase
Shipping fee: Limited-time free


Product Description

Catalog ID pGMAAV000143
Gene Name Cav1
Accession Number NM_007616.4
Gene ID 12389
Species Mouse
Product Type Adeno-associate virus(AAV) plasmid (overexpression)
Insert Length 537 bp
Gene Alias Cav,Cav-1
Fluorescent Reporter GFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector vGMAAV000143 Mouse Cav1 Adeno-associate virus(AAV) particle




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.